ABSTRACT -
ClearView® gel is similar to current radiochromic gels in that, upon irradiation, physical color changers in the gel are present. These color changes are proportional to the dose received by the gel, thus retaining the dose information after dose delivery is complete. The resulting color concentration can then be 55 measured as an optical density (OD) using optical computed tomography (CT). However, ClearView® offers some notable advantages over standard Fricke radiochromic gels. Unlike Fricke gels, ClearView®'s tetrazoleum salt formula does not suffer from spatial diffusion common in xylenol orange gels which causes a loss of spatial dose information over time. [2] [3] ClearView® also has the capability to measure doses of up to 80 Gy, where only doses of up to 40 Gy are measureable with specific oxygen-purged
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Fricke gels. 4 The main advantage that both ClearView® and polymer gels share over Fricke radiochromic gels is the absence of spatial diffusion which causes errors in dose distribution. [5] [6] Additionally, most polymer gels display properties such as high reproducibility, well-defined spatial distribution, and low dose-rate dependence, which are favorable for SRS QA. 7 However, polymer gel dosimeters are not without problems of their own. Additionally, polymeric radicals used to report dose in polymer gel disadvantages are that the scanner is quite expensive, as it is a modern product with advanced software associated with it. It is projected that most centers will find the system too expensive to have on-site, which therefore requires the shipping of samples with no real-time result. With shipping necessary, it is important that the user adhere to the refrigeration guidelines of the manufacturer, to prevent the 
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MATERIALS & METHODS
Dosimetry for this study was conducted using ClearView® gel, which is formed on the basis of gellan gum makes use of cone beam computed tomography technology (Vista® 15 scanner) for a three-dimensional rendering of the gel using a 620-633 nm (orange-dark orange) photon light source with a narrow bandwidth. 18 The change in optical density (OD) of the gel after irradiation is then directly proportional to the absorbed dose, using only the proportionality constant and the linear attenuation coefficient.
Together, these properties relate the chemical reduction sensitivity of the salt colloid to the amount of energy absorbed by the gel. From this relationship, only the determination of OD from the visible light
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CT scanner remains. 14, 18 ClearView® gels were scanned before shipping by the manufacturer to establish a baseline and independent calibration for each vial.
Once the gel vial was received and unpackaged from the manufacturer's ice-packed container, the gel vial was permitted to warm to room temperature for 8 hours before use. Each vial was 9.0 cm long, 4.3 140 cm in diameter, and has a wall thickness of 1.0 mm. Localization fiducials were placed non-coplanar at three different locations on the surface of the vial. The metal fiducial spheres were expected to easily make their location known at the time of gel vial scanning, where triangulation of the scanning geometry to the planned geometry would be possible. In order to enable mounting of the vial, a small adaptor was fabricated out of acrylic. The adaptor was simple in form, being flat at one end and 145 threaded on the opposite end. To secure the gel vial into a stationary position, the acrylic adaptor was mounted to the lid of the gel vial with a strong adhesive. After the glue cured, the opposite end of the Each beam had an x-ray energy of 6 MV-FFF assigned to that isocenter and can be described by IEC 6-1217 standard geometry with static table positions (T) and gantry (G) rotations. 24 Specifically, these 
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accompanying cone-beam CT (CBCT) to be performed prior to the SRS delivery. Image registration was expected to correct for any inaccuracies in the raw alignment of the phantom that differed from planned geometry once mounted to the couch of the accelerator. This adjustment was made simple using the six-degree of freedom (6DOF) couch.
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The integrity of the linear accelerator isocenter was determined by various imaging modalities. Isocenter checks included the placement of a (5 cm) 3 cube, having in internally centered fiducial, on the couch of anteriorly imaged using a 6 MV beam by the electronic portal imaging device (EPID) as well as using a laterally projected 120 kVp beam by the On-board Imager. [25] [26] [27] Following that check, a CBCT scan was
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performed with the OBI. Finally, a Winston-Lutz procedure was introduced for further quality assurance (QA). 28 This process makes use of the cube and EPID again. However, images are taken at a variety of oblique angle couch and gantry positions.
The head phantom was then attached to the end treatment couch using the halo screws as done for the
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CT scan. In-room wall lasers were used to assist the initial raw visual set-up in positioning the center of the head phantom roughly to the isocenter. Set-up of the head phantom detailing the position of the gel vial inside is depicted in Figure 2 . mechanism at the neck of the head phantom was carefully unlocked, permitting the release of the rod, adaptor, and gel vial assembly. After the adaptor was unscrewed from the rod, the remaining gel vial and affixed adaptor were permitted to dry before being shipped back to the manufacturer for scanning.
The gels were scanned two days after irradiation at the manufacturer's facility.
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RESULTS
Appearance of the purple-colored formazan dye was evident immediately after radiation. A darker hue of dye concentrated at the center of the vial agreed with our expectations. 29 Proof of color change in the gel is evident in Figure 3 , where the purple haze appears at the center of the vial. Dosimetry results
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were first compared between the plan and the measured scan for the three principal planes of view:
axial, coronal and sagittal. 
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Tools within Vista®View software further permit comparisons in dose using cross-plots. Plots were generated from the wall of the vial through each axis for a direct comparison of dose planned and 
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We accounted for five systematic uncertainties in this research. First, there was an observed potential inaccuracy in the manual alignment of the acrylic adaptor. As stated earlier, we affixed a vial-rod adaptor to the plastic vial in order to make it possible to connect to the RSVP Phantom II rod. We knew that each ClearView® gel vial was scanned prior to irradiation in order to establish a baseline. At that 260 time, the vial-rod adaptor was attached to the gel vial. It was later disconnected during transit. Upon reattachment, the re-alignment was made possible by delineated 1.0 mm wide marker lines. Although we made every effort possible to reduce misalignment by matching the center of the lines marked, the uncertainty of δ1 = 1.0 mm was noted as possible.
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During linear accelerator QA, the Winston-Lutz test revealed that the combination of gantry and couch rotations provide for an additional δ2 = 0.6 mm in isocenter displacement. Given that the treatment plan called for both gantry and couch rotational deliveries, this uncertainty must be included. Prior to dose delivery, we made use of a CBCT registration technique to match the external surface geometry of the phantom in the treatment vault to that of the plan. The uncertainty in CBCT registration is the Table 1 . 
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